Abstract
Clinically significant antibiotic resistance has evolved against virtually every antibiotic deployed. Yet the development of new classes of antibiotics has lagged far behind our growing need for such drugs. Antimicrobial peptides (AMPs) have emerged as novel therapeutics hailed for their bactericidal and immunomodulatory properties. However, the process of optimizing antimicrobial peptide stability, using large peptide libraries is both tedious and expensive. The intent of this study is to analyze computationally the stability of anti-bacterial peptides (ABPs), particularly Gram positive and to discover a potential template from a pool of ABPs for therapeutic use. Consequently we highlighted that MiAMP1 appears advantageous over the other ABPs with respect to stability, and may provide a convenient platform for the development of anti-bacterial therapeutic peptide.
Similar content being viewed by others
References
Baker, E.N., Hubbard, R.E. 1984. Hydrogen bonding in globular proteins. Prog Biophys Mol Biol 44, 97–179.
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E. 2000. The Protein Data Bank. Nucleic Acids Res 28, 235–242.
Boman, H.G. 2003. Antibacterial peptides: Basic facts and emerging concepts. J Intern Med 254, 197–215.
Borg, M.A. 2003. Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings. J Hosp Infect 54, 316–318.
Brogden, K.A., Ackermann, M., McCray, P.B.J., Tack, B.F. 2003. Antimicrobial peptides in animals and their role in host defences. Int J Antimicrob Agents 22, 465–478.
Bulet, P., Stocklin, R., Menin, L. 2004. Anti-microbial peptides: From invertebrates to vertebrates. Immunol Rev 198, 169–184.
Burley, S.K., Petsko, G.A. 1986. Amino-aromatic interactions in proteins. FEBS Letters 203, 139–143.
Burley, S.K., Petsko, G.A. 1988. Weakly polar interactions in proteins. Adv Protein Chem 39, 125–189.
Davies, J. 1996. Bacteria on the rampage. Nature 383, 219–220.
Desiraju, G.R. 1991. TheC-H…O hydrogen bonding crystals: What is it? Acc Chem Res 24, 290–296.
Dill, K.A. 1990. Dominant forces in protein folding. Biochemistry 29, 7133–7155.
Dosztanyi, Z., Fiser, A., Simon, I. 1997. Stabilization centers in proteins: Identification, characterization and predictions. J Mol Biol 272, 597–612.
Dosztanyi, Z.S., Magyar, C.S., Tusnady, E.G., Simon, I. 2003. SCide: Identification of stabilization centers in proteins. Bioinformatics 19, 899–900.
Enright, M.C. 2003. The evolution of a resistant pathogen — the case of MRSA. Curr Opin Pharmacol 3, 474–479.
Finlay, B.B., Hancock, R.E. 2004. Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol 2, 497–504.
Gallivan, J.P., Dougherty, D.A. 1999. Cation-π interactions in structural biology. Proc Natl Acad Sci USA 96, 9459–9464.
Gallo, R.L., Kim, K.J., Bernfield, M. 1997. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 272, 3088–3093.
Giuliani, A., Pirri, G., Nicoletto, S.F. 2007. Antimicrobial peptides: An overview of a promising class of therapeutics. Cen Eur J Biol 2, 1–33.
Guex, N., Peitsch, M.C. 1997. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 18, 2714–2723.
Guruprasad, K., Reddy, B.V.B., Pandit, M.W. 1990. Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng 4, 155–161.
Hamman, J.H., Enslin, G.M., Kotze, A.F. 2005. Oral delivery of peptide drugs: Barriers and developments. BioDrugs 19, 165–177.
Him, H.J., Steif, C., Vogl, T., Meyer, R., Renner, M., Ledermiiller, R. 1993. Fundamentals of protein stability. Pure & Appl Chern 65, 947–952.
Janek, K., Rothemund, S., Gast, K., Beyermann, M., Zipper, J., Fabian, H., Bienert, M., Krause, E. 2001. Study of the conformational transition of A beta (1–42) using D-amino acid replacement analogues. Biochemistry 40, 5457–5463.
Jeffrey, G.A., Saenger, W. 1993. Hydrogen bonding in biological structures. Biophys J 64, 21–25.
Koczulla, A.R., Bals, R. 2003. Antimicrobial peptides — Current status and therapeutics potential. Drugs 63, 389–406.
Loffet, A. 2002. Peptides as drugs: Is there a market? J Pept Sci 8, 1–7.
Marcus, J.P., Goulter, K.C., Green, J.L., Harrison, S.J., Manners, J.M. 1997. Purification, characterisation and cDNA cloning of an antimicrobial peptide from Macadamia integrifolia. Eur J Biochem 244, 743–749.
McManus, A.M., Nielsen, K.J., Marcus, J.P., Harrison, S.J., Green, J.L., Manners, J.M., Craik, D.J. 1999. MiAMP1, a novel protein from Macadamia integrifolia adopts a Greek key beta-barrel fold unique amongst plant antimicrobial proteins. J Mol Biol 293, 629–638.
Moll, A., Hildebrandt, A., Lenhof, H. P., Kohlbacher, O. 2005. BALLView: An object-oriented molecular visualization and modeling framework. J Comput Aided Mol Des 11, 791–800.
Moll, A., Hildebrandt, A., Lenhof, H.P., Kohlbacher, O. 2006. BALLView: A tool for research and education in molecular modeling. Bioinformatics 22, 365–366.
Mor, A. 2000. Peptide-based antibiotics: A potential answer to raging antimicrobial resistance. Drug Dev Res 50, 440–447.
Nishio, M., Hirota, M., Umezawa, Y. 1998. The CH/π Interaction. Wiley-VCH, New York.
Pace, C.N., Shirley, B.A., McNutt, M., Gajiwala, K. 1996. Forces contributing to the conformational stability of proteins. FASEB J 10, 75–83.
Ramanathan, K., Sethumadhavan, R., 2009. Exploring the role of C-H…π interactions on the structural stability of antimicrobial peptides. J Theor Comput Chem 8, 909–924.
Ramanathan, K., Shanthi, V., Sethumadhavan, R. 2009. Contribution of unconventional C-H…O bonds to the structural stability of antimicrobial peptides. Interdiscip Sci Comput Life Sci 1, 263–271.
Sawa, T., Kurahashi, K., Ohara, M. 1998. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob Agents Chemother 42, 3269–3275.
Stephens, C., Kazan, K., Goulter, K.C., Maclean, D.J., Manners, J.M. 2005. The mode of action of the plant antimicrobial peptide MiAMP1 differs from that of its structural homologue, the yeast killer toxin WmKT. FEMS Microbiol Lett 243, 205–210.
Tiwari, A., Panigrahi, S.K. 2007. HBAT: A complete package for analyzing strong and weak hydrogen bonds in macro molecular crystal structures. In Silico Biol 7, 0057.
Tonks, A. 1994. Drug resistance is a worldwide threat, warns report. BMJ 309, 1109–1110.
Travis, S.M., Anderson, N.N., Forsyth, W.R. 2000. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 68, 2748–2755.
Vriend, G. 1990. WHAT IF: A molecular modeling and drug design program. J Mol Graph 8, 52–56.
Wahl, M.C., Sundaralingam, M. 1997. C-H…O hydrogen bonding in biology. Trends Biochem Sci 22, 97–102.
Wang, G., Li, X., Wang, Z. 2009. APD2: The updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37, D933–D937.
Zanetti, M., Gennaro, R., Romeo, D. 1995. Cathelicidins: A novel protein family with a common proregion and a variabe C-terminal antimicrobial domain. FEBS Lett 374, 1–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramanathan, K., Sethumadhavan, R. Identifying therapeutic template by evaluating the structural stability of gram positive anti-bacterial peptides-a computational approach. Interdiscip Sci Comput Life Sci 3, 182–188 (2011). https://doi.org/10.1007/s12539-011-0088-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12539-011-0088-3